Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Development of a solid dosage platform for the oral delivery of bilayer vesicles.

Wilkhu JS, McNeil SE, Anderson DE, Kirchmeier M, Perrie Y.

Eur J Pharm Sci. 2017 Oct 15;108:71-77. doi: 10.1016/j.ejps.2017.06.014. Epub 2017 Jun 12.

2.

Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity.

Kirchmeier M, Fluckiger AC, Soare C, Bozic J, Ontsouka B, Ahmed T, Diress A, Pereira L, Schödel F, Plotkin S, Dalba C, Klatzmann D, Anderson DE.

Clin Vaccine Immunol. 2014 Feb;21(2):174-80. doi: 10.1128/CVI.00662-13. Epub 2013 Dec 11.

3.

Investigating the role of cholesterol in the formation of non-ionic surfactant based bilayer vesicles: thermal analysis and molecular dynamics.

Wilkhu JS, Ouyang D, Kirchmeier MJ, Anderson DE, Perrie Y.

Int J Pharm. 2014 Jan 30;461(1-2):331-41. doi: 10.1016/j.ijpharm.2013.11.063. Epub 2013 Dec 11.

4.

Electrostatic interactions of monoclonal antibodies with subcutaneous tissue.

Mach H, Gregory SM, Mackiewicz A, Mittal S, Lalloo A, Kirchmeier M, Shameem M.

Ther Deliv. 2011 Jun;2(6):727-36.

PMID:
22822505
5.

Monoclonal antibody aggregation intermediates visualized by atomic force microscopy.

Lee H, Kirchmeier M, Mach H.

J Pharm Sci. 2011 Feb;100(2):416-23. doi: 10.1002/jps.22279.

PMID:
20653051
6.

Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody.

Vlasak J, Bussat MC, Wang S, Wagner-Rousset E, Schaefer M, Klinguer-Hamour C, Kirchmeier M, Corvaïa N, Ionescu R, Beck A.

Anal Biochem. 2009 Sep 15;392(2):145-54. doi: 10.1016/j.ab.2009.05.043. Epub 2009 Jun 2.

PMID:
19497295
7.

Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies.

Ionescu RM, Vlasak J, Price C, Kirchmeier M.

J Pharm Sci. 2008 Apr;97(4):1414-26.

PMID:
17721938
8.

Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells.

Ishida T, Kirchmeier MJ, Moase EH, Zalipsky S, Allen TM.

Biochim Biophys Acta. 2001 Dec 1;1515(2):144-58.

9.

Intrathecal application with liposome-entrapped Fasudil for cerebral vasospasm following subarachnoid hemorrhage in rats.

Takanashi Y, Ishida T, Meguro T, Kirchmeier MJ, Allen TM, Zhang JH.

J Clin Neurosci. 2001 Nov;8(6):557-61.

PMID:
11683605
10.

A novel drug delivery system as prophylaxis for cerebral vasospasm.

Takanashi Y, Ishida T, Meguro T, Kirchmeier MJ, Allen TM, Zhang JH.

Acta Neurochir Suppl. 2001;77:213-5. No abstract available.

PMID:
11563290
11.

Neuroprotection by intrathecal application of liposome-entrapped fasudil in a rat model of ischemia.

Takanashi Y, Ishida T, Kirchmeier MJ, Shuaib A, Allen TM.

Neurol Med Chir (Tokyo). 2001 Mar;41(3):107-13; discussion 113-4.

12.

Correlations between the rate of intracellular release of endocytosed liposomal Doxorubicin and cytotoxicity as determined by a new assay.

Kirchmeier MJ, Ishida T, Chevrette J, Allen TM.

J Liposome Res. 2001;11(1):15-29. doi: 10.1081/LPR-100103167.

PMID:
19530916
13.

GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide.

Pagnan G, Montaldo PG, Pastorino F, Raffaghello L, Kirchmeier M, Allen TM, Ponzoni M.

Int J Cancer. 1999 Apr 12;81(2):268-74.

14.

N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell death.

Montaldo PG, Pagnan G, Pastorino F, Chiesa V, Raffaghello L, Kirchmeier M, Allen TM, Ponzoni M.

Int J Cancer. 1999 Apr 12;81(2):262-7.

Supplemental Content

Loading ...
Support Center